Pentwater Capital Management LP Seagen Inc. Put Options Transaction History

Pentwater Capital Management LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $785 Million - $886 Million	4,097,700 Added 72.72%	9,732,600 $2.06 Billion
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $861 Million - $947 Million	4,589,900 Added 439.22%	5,634,900 $1.08 Billion
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $133 Million - $212 Million	1,045,000 New	1,045,000 $212 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.